Suppr超能文献

组织激肽释放酶与激肽:在人类疾病中的作用及新药开发靶点

Tissue kallikreins and kinins: roles in human disease and target for new drug development.

作者信息

Margolius H S

机构信息

Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425.

出版信息

Adv Exp Med Biol. 1989;247A:1-6. doi: 10.1007/978-1-4615-9543-4_1.

Abstract

There is no convincing evidence presently for the notion that tissue kallikrein-regulated systems are the proximate cause of any form of human or animal disease. Nevertheless, the collection of facts very briefly mentioned here, suggest strongly that all of the conditions for such a possibility are being met and the right questions about such possibilities are being asked. Even without the answers, it is quite possible to anticipate what the abnormalities might be, and try to devise rational therapeutic strategies and new drugs. This is an area of endeavor which will be worthwhile because it will allow us to learn more about how kininogens, kallikreins, kinins and kininases function, even as new therapies are created.

摘要

目前尚无令人信服的证据支持组织激肽释放酶调节系统是任何形式的人类或动物疾病的直接原因这一观点。然而,这里简要提及的一系列事实有力地表明,这种可能性的所有条件都已具备,并且正在提出关于此类可能性的恰当问题。即使没有答案,也很有可能预测到可能出现的异常情况,并尝试制定合理的治疗策略和研发新药。这是一个值得努力的领域,因为即使在创造新疗法的同时,它也将使我们更多地了解激肽原、激肽释放酶、激肽和激肽酶的功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验